These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


802 related items for PubMed ID: 32565281

  • 1. 99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent.
    El-Ghareb WI, Swidan MM, Ibrahim IT, Abd El-Bary A, Tadros MI, Sakr TM.
    Int J Pharm; 2020 Aug 30; 586():119514. PubMed ID: 32565281
    [Abstract] [Full Text] [Related]

  • 2. pH-Sensitive doxorubicin delivery using zinc oxide nanoparticles as a rectified theranostic platform: in vitro anti-proliferative, apoptotic, cell cycle arrest and in vivo radio-distribution studies.
    Swidan MM, Marzook F, Sakr TM.
    J Mater Chem B; 2024 Jun 27; 12(25):6257-6274. PubMed ID: 38845545
    [Abstract] [Full Text] [Related]

  • 3. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging.
    Zhu J, Wang G, Alves CS, Tomás H, Xiong Z, Shen M, Rodrigues J, Shi X.
    Langmuir; 2018 Oct 16; 34(41):12428-12435. PubMed ID: 30251859
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS, Fathy MM, Khalil WM.
    Phys Med; 2014 Nov 16; 30(7):843-8. PubMed ID: 24950615
    [Abstract] [Full Text] [Related]

  • 5. Multi-functional core-shell Fe3O4@Au nanoparticles for cancer diagnosis and therapy.
    S R, M P.
    Colloids Surf B Biointerfaces; 2019 Feb 01; 174():252-259. PubMed ID: 30469046
    [Abstract] [Full Text] [Related]

  • 6. Multifunctional 99mTc-5-azacitidine Gold Nanoparticles: Formulation, In Vitro Cytotoxicity, Radiosynthesis, and In Vivo Pharmacokinetic Study.
    Eldin SSE, Rashed HM, Hassan AH, Salem HF, Sakr TM.
    Curr Drug Deliv; 2023 Feb 01; 20(4):387-399. PubMed ID: 35339176
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy.
    Shao Y, Luo W, Guo Q, Li X, Zhang Q, Li J.
    Drug Des Devel Ther; 2019 Feb 01; 13():2043-2055. PubMed ID: 31388296
    [Abstract] [Full Text] [Related]

  • 8. Amelioration of Tumor Targeting and In Vivo Biodistribution of 99mTc-Methotrexate-Gold Nanoparticles (99mTc-Mex-AuNPs).
    El-Safoury DM, Ibrahim AB, El-Setouhy DA, Khowessah OM, Motaleb MA, Sakr TM.
    J Pharm Sci; 2021 Aug 01; 110(8):2955-2965. PubMed ID: 33812886
    [Abstract] [Full Text] [Related]

  • 9. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F, Zheng C, Xin J, Chen F, Ling H, Sun L, Webster TJ, Ming X, Liu J.
    Int J Nanomedicine; 2016 Aug 01; 11():3875-90. PubMed ID: 27574421
    [Abstract] [Full Text] [Related]

  • 10. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A, Mokrish A, Mansor R, Razak ISA, Danmaigoro A, Jaji AZ, Bakar ZA.
    Int J Nanomedicine; 2019 Aug 01; 14():3615-3627. PubMed ID: 31190815
    [Abstract] [Full Text] [Related]

  • 11. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
    Lin W, Yao N, Qian L, Zhang X, Chen Q, Wang J, Zhang L.
    Acta Biomater; 2017 Aug 01; 58():455-465. PubMed ID: 28583900
    [Abstract] [Full Text] [Related]

  • 12. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H, Yang DP, Liu M, Wang X, Zhang Z, Zhou G, Liu W, Cao Y, Zhang WJ, Wang X.
    Int J Nanomedicine; 2017 Aug 01; 12():2829-2843. PubMed ID: 28435261
    [Abstract] [Full Text] [Related]

  • 13. 99mTc Radiolabeled HA/TPGS-Based Curcumin-Loaded Nanoparticle for Breast Cancer Synergistic Theranostics: Design, in vitro and in vivo Evaluation.
    Huang C, Chen F, Zhang L, Yang Y, Yang X, Pan W.
    Int J Nanomedicine; 2020 Aug 01; 15():2987-2998. PubMed ID: 32431497
    [Abstract] [Full Text] [Related]

  • 14. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu P, Sapin-Minet A, Maincent P, Hong XC, Hu XM, Xiao YL.
    Mol Pharm; 2015 Mar 02; 12(3):675-83. PubMed ID: 25584860
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.
    Imanimoghadam M, Yaghoobi E, Alizadeh F, Ramezani M, Alibolandi M, Abnous K, Taghdisi SM.
    J Pharm Sci; 2024 Jul 02; 113(7):1865-1873. PubMed ID: 38342338
    [Abstract] [Full Text] [Related]

  • 17. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
    He Z, Jiang H, Zhang X, Zhang H, Cui Z, Sun L, Li H, Qian J, Ma J, Huang J.
    Pharmacol Res; 2020 Oct 02; 160():105184. PubMed ID: 32946931
    [Abstract] [Full Text] [Related]

  • 18. Combined Chemo- and Photothermal Therapies of Non-Small Cell Lung Cancer Using Polydopamine/Au Hollow Nanospheres Loaded with Doxorubicin.
    Zhang X, Xu B, Ni J, Xiang Y, He Z.
    Int J Nanomedicine; 2024 Oct 02; 19():9597-9612. PubMed ID: 39296938
    [Abstract] [Full Text] [Related]

  • 19. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
    Lin W, Zhang X, Qian L, Yao N, Pan Y, Zhang L.
    Biomacromolecules; 2017 Dec 11; 18(12):3869-3880. PubMed ID: 29032674
    [Abstract] [Full Text] [Related]

  • 20. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F.
    Eur J Pharm Biopharm; 2015 Aug 11; 94():521-31. PubMed ID: 26170161
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.